Back to Trades
Denali Therapeutics Inc.
DNLICIK: 0001714899
Follow DNLI
Track Denali Therapeutics Inc. insider trades on your dashboard. Email alerts with a subscription.
Denali Therapeutics Inc. (DNLI) has recorded 22 insider filings from 12 unique insiders, totaling $20.1M in trading activity (net selling). Insiders have sold $8.4M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Watts Ryan J.. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$20.1M
Purchases
$0
Sales
$8.4M
Unique Insiders
12
Recent Insider Trades
22 loaded
| Jun 5 | DNLI Denali Therapeutics Inc. | Cook Jennifer E. | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | Thornberry Nancy | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | Krognes Steve E. | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | FLATLEY JAY T | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | Klein Peter S | Director | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | Schenkein David P | Director | Grant | $0 |
| Apr 20 | DNLI Denali Therapeutics Inc. | Chin Peter Scott | Chief Medical Officer | Other | $0 |
| Apr 21 | DNLI Denali Therapeutics Inc. | Chin Peter Scott | Chief Medical Officer | Other | $0 |
| Jan 8 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Sell | $580.8K |
| Jan 8 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $284.1K |
| Jan 5 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Grant | $0 |
| Jan 5 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Grant | $0 |
| Dec 15 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Nov 6 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Other | $0 |
| Nov 6 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Grant | $0 |
| Sep 5 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Gift | $0 |
| Aug 14 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | $51.7K |
| Aug 14 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $39.9K |
| Aug 7 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Other | $0 |
| Jul 11 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Sell | $7.4M |
22 filings